Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 56 | $87,282,127 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 28 Oct 2024 21:48 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 28 Oct 2024 | Sale | 49,672 | 74.559 | 3,703,495 | D |
| 28 Oct 2024 21:48 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 28 Oct 2024 | Sale | 18,620 | 75.786 | 1,411,135 | D |
| 28 Oct 2024 21:48 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 28 Oct 2024 | Sale | 9,265 | 76.935 | 712,803 | D |
| 28 Oct 2024 21:48 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 28 Oct 2024 | Sale | 23,082 | 77.6804 | 1,793,019 | D |
| 28 Oct 2024 21:48 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 28 Oct 2024 | Sale | 15,825 | 78.6907 | 1,245,280 | D |
| 28 Oct 2024 21:48 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 28 Oct 2024 | Sale | 6,050 | 79.7793 | 482,665 | D |
| 28 Oct 2024 21:48 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 28 Oct 2024 | Sale | 7,967 | 80.6508 | 642,545 | D |
| 28 Oct 2024 21:48 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 28 Oct 2024 | Sale | 1,206 | 81.4447 | 98,222 | D |
| 25 Oct 2024 19:28 | VKTX | Viking Therapeutics Inc | ROUAN SARAH KATHRYN | Director | 25 Oct 2024 | Sale | 11,000 | 80.89 | 889,790 | D |
| 25 Oct 2024 19:27 | VKTX | Viking Therapeutics Inc | SINGLETON J MATTHEW | Director | 25 Oct 2024 | Sale | 16,000 | 79.5 | 1,272,000 | D |
| 20 Sep 2024 21:21 | VKTX | Viking Therapeutics Inc | SINGLETON J MATTHEW | Director | 20 Sep 2024 | Sale | 10,300 | 69.5 | 715,850 | D |
| 20 Sep 2024 21:20 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 20 Sep 2024 | Sale | 200 | 71.985 | 14,397 | D |
| 20 Sep 2024 21:20 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 20 Sep 2024 | Sale | 119,874 | 71.1501 | 8,529,047 | D |
| 20 Sep 2024 21:20 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 20 Sep 2024 | Sale | 96,056 | 70.4288 | 6,765,109 | D |
| 22 Aug 2024 19:23 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 21 Aug 2024 | Sale | 1,000 | 69.9 | 69,900 | D |
| 22 Aug 2024 19:23 | VKTX | Viking Therapeutics Inc | SINGLETON J MATTHEW | Director | 21 Aug 2024 | Sale | 5,700 | 69.7246 | 397,430 | D |
| 19 Aug 2024 20:13 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 19 Aug 2024 | Sale | 11,296 | 67.1206 | 758,194 | D |
| 19 Aug 2024 20:13 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 19 Aug 2024 | Sale | 31,442 | 66.3705 | 2,086,821 | D |
| 19 Aug 2024 20:13 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 19 Aug 2024 | Sale | 70,132 | 65.3267 | 4,581,492 | D |
| 19 Aug 2024 20:11 | VKTX | Viking Therapeutics Inc | SINGLETON J MATTHEW | Director | 19 Aug 2024 | Sale | 1,501 | 64.8798 | 97,385 | D |
| 19 Aug 2024 20:11 | VKTX | Viking Therapeutics Inc | SINGLETON J MATTHEW | Director | 19 Aug 2024 | Sale | 2,388 | 64.1037 | 153,080 | D |
| 19 Aug 2024 20:11 | VKTX | Viking Therapeutics Inc | SINGLETON J MATTHEW | Director | 19 Aug 2024 | Sale | 2,055 | 63.1509 | 129,775 | D |
| 19 Aug 2024 20:11 | VKTX | Viking Therapeutics Inc | SINGLETON J MATTHEW | Director | 19 Aug 2024 | Sale | 4,509 | 61.861 | 278,931 | D |
| 19 Aug 2024 20:11 | VKTX | Viking Therapeutics Inc | SINGLETON J MATTHEW | Director | 19 Aug 2024 | Sale | 3,047 | 61.1251 | 186,248 | D |
| 19 Aug 2024 20:11 | VKTX | Viking Therapeutics Inc | SINGLETON J MATTHEW | Director | 19 Aug 2024 | Sale | 2,500 | 60.0138 | 150,034 | D |
| 14 Aug 2024 20:03 | VKTX | Viking Therapeutics Inc | SINGLETON J MATTHEW | Director | 14 Aug 2024 | Sale | 160 | 58.3688 | 9,339 | D |
| 14 Aug 2024 20:03 | VKTX | Viking Therapeutics Inc | SINGLETON J MATTHEW | Director | 14 Aug 2024 | Sale | 20,626 | 57.5195 | 1,186,397 | D |
| 31 Jul 2024 16:05 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 30 Jul 2024 | Sale | 2,974 | 57.71 | 171,630 | D |
| 31 Jul 2024 16:05 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 30 Jul 2024 | Sale | 500 | 58.71 | 29,355 | D |
| 31 Jul 2024 16:05 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 30 Jul 2024 | Sale | 12,662 | 56.96 | 721,228 | D |
| 31 Jul 2024 16:05 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 30 Jul 2024 | Sale | 30,417 | 58.78 | 1,787,911 | D |
| 31 Jul 2024 16:05 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 30 Jul 2024 | Sale | 19,501 | 57.81 | 1,127,353 | D |
| 31 Jul 2024 16:05 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 30 Jul 2024 | Sale | 65,941 | 56.95 | 3,755,340 | D |
| 31 Jul 2024 16:05 | VKTX | Viking Therapeutics Inc | MANCINI MARIANNA | Chief Operating Officer | 30 Jul 2024 | Sale | 3,322 | 57.82 | 192,078 | D |
| 31 Jul 2024 16:05 | VKTX | Viking Therapeutics Inc | MANCINI MARIANNA | Chief Operating Officer | 30 Jul 2024 | Sale | 14,704 | 56.98 | 837,834 | D |
| 03 May 2024 20:51 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 03 May 2024 | Sale | 847 | 76.0743 | 64,435 | D |
| 03 May 2024 20:51 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 03 May 2024 | Sale | 17,238 | 75.4868 | 1,301,241 | D |
| 03 May 2024 20:51 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 03 May 2024 | Sale | 45,570 | 74.4447 | 3,392,445 | D |
| 03 May 2024 20:51 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 03 May 2024 | Sale | 3,101 | 73.4881 | 227,887 | D |
| 02 May 2024 21:27 | VKTX | Viking Therapeutics Inc | MANCINI MARIANNA | Chief Operating Officer | 01 May 2024 | Sale | 6,248 | 80.0753 | 500,310 | D |
| 02 May 2024 21:27 | VKTX | Viking Therapeutics Inc | MANCINI MARIANNA | Chief Operating Officer | 01 May 2024 | Sale | 105,343 | 78.6476 | 8,284,974 | D |
| 02 May 2024 21:27 | VKTX | Viking Therapeutics Inc | MANCINI MARIANNA | Chief Operating Officer | 01 May 2024 | Sale | 119,946 | 79.2945 | 9,511,058 | D |
| 02 May 2024 21:27 | VKTX | Viking Therapeutics Inc | MANCINI MARIANNA | Chief Operating Officer | 01 May 2024 | Sale | 26,142 | 77.4933 | 2,025,830 | D |
| 02 May 2024 21:27 | VKTX | Viking Therapeutics Inc | MANCINI MARIANNA | Chief Operating Officer | 01 May 2024 | Sale | 23,746 | 76.4045 | 1,814,301 | D |
| 09 Feb 2024 20:59 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 09 Feb 2024 | Sale | 45,000 | 29.9 | 1,345,500 | D |
| 08 Feb 2024 19:40 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 08 Feb 2024 | Sale | 40,000 | 28.9 | 1,156,000 | D |
| 08 Feb 2024 19:40 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 08 Feb 2024 | Sale | 40,000 | 27.45 | 1,098,000 | D |
| 08 Feb 2024 19:40 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 08 Feb 2024 | Sale | 80,000 | 26.95 | 2,156,000 | D |
| 08 Feb 2024 19:40 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 08 Feb 2024 | Sale | 60,000 | 25.95 | 1,557,000 | D |
| 08 Feb 2024 19:40 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 08 Feb 2024 | Sale | 49,079 | 25.75 | 1,263,784 | D |
| 08 Feb 2024 19:38 | VKTX | Viking Therapeutics Inc | ROUAN SARAH KATHRYN | Director | 08 Feb 2024 | Sale | 25,000 | 28.05 | 701,250 | D |
| 31 Jan 2024 20:39 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 31 Jan 2024 | Sale | 40,000 | 24.45 | 978,000 | D |
| 31 Jan 2024 20:39 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 31 Jan 2024 | Sale | 45,000 | 24.95 | 1,122,750 | D |
| 30 Jan 2024 21:05 | VKTX | Viking Therapeutics Inc | LIAN BRIAN | President & CEO | 30 Jan 2024 | Sale | 35,000 | 23.95 | 838,250 | D |
| 19 Jan 2024 20:35 | VKTX | Viking Therapeutics Inc | ROUAN SARAH KATHRYN | Director | 19 Jan 2024 | Sale | 30,000 | 23.05 | 691,500 | D |
| 04 Jan 2024 21:35 | VKTX | Viking Therapeutics Inc | ZANTE GREG | Chief Financial Officer | 04 Jan 2024 | Sale | 15,000 | 17.9 | 268,500 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)